HB0077 introduced to schedule xylazine as a Schedule III controlled substance with statutory exemptions

Illinois HB0077 (104th GA) proposes amending the Illinois Controlled Substances Act to schedule xylazine as a Schedule III controlled substance and establish xylazine-specific exemptions (per introduced bill text). Compliance relevance: if enacted, it would add xylazine to Illinois scheduling, changing controlled substance compliance obligations for entities that handle xylazine, with exemptions particularly relevant to veterinary and authorized-use contexts.